Access Africa Guidelines on Post-Trial Access for international Clinical Trials in Sub-Saharan Africa

Domain:

healthcare

Record type:

policy

Creator:

Mba

Publisher:

Host:

This is a presentation on improving post-trial access (PTA) arrangements in clinical trials conducted in low- and middle-income countries (LMICs), particularly in Sub-Saharan Africa. The main focus is on establishing ethical, practical, and equitable measures for post-trial access in clinical trials, and creating collaborative frameworks involving stakeholders such as funders, drug regulators, communities, and research ethics committees. This was presented at The Forum for Ethical Review Committees in the Asian and Western Pacific Region Conference 2025 (FERCAP). The full guideline may be accessed here: zenodo.org

Visit

doi.org zenodo.org

Licenses

Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode

Chemotherapy Access - Sub-Saharan Africa

⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suita

Bridging the Gap for Sickle Cell Disease Patient Data in Sub-Saharan Africa By Expanding Access to Specialty Biomarkers and Clinical Trials

The pipeline of clinical trials for sickle cell disease (SCD) therapies has expanded substantially,

IMPROVING EFFICIENCY AND QUALITY IN CLINICAL TRIALS IN SUB-SAHARAN AFRICA

Background Conduct of clinical trials is significantly regulated and requires su

Making clinical trials a public norm for health decisions in sub-Saharan Africa

PO 8564 WHAT IS CLINICAL TRIAL QUALITY? A QUALITATIVE STUDY BASED ON INTERVIEWS WITH DIFFERENT STAKEHOLDERS CONDUCTING CLINICAL TRIALS IN SUB-SAHARAN AFRICA

Background There is no unified, broad definition for quality in clinical trials

Determinants of Clean Energy Access in Sub-Saharan Africa

Access to clean energy remains a critical challenge in Sub-Saharan Africa (SSA), where over 80% of h